companydata.dkcompanydata.dk

Novomedicon ApS: Financial statements 2021

CVR: 38818791

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Novomedicon ApS (CVR 38818791) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -522 compared with DKK -4,643 the year before. Equity in the 2021 report amounted to DKK 34,835. The solvency ratio was 87.2%.

Profit/Loss
DKK -522
Equity
DKK 34,835
Total Assets
DKK 39,947

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021---52235K-
2020-0-5K-5K1
2019-001001
20180000-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Novomedicon ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Novomedicon IVS changes name to Novomedicon ApSSep 30, 2021

On September 30, 2021, the company changed its name from Novomedicon IVS to Novomedicon ApS.

Novomedicon ApS: The 2020 annual report is outApr 14, 2021

Novomedicon ApS has published its annual report for 2020. Gross profit came to DKK 0, and the net result was DKK -4,643.

About Novomedicon ApS

Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.

Source: annual report 2025, Danish Business Authority

Other financial years